Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Zoe Getchell

1PUBLICATIONS

27CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 11, 2023

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

Brandon M Huffman, Hanrong Feng, Kalindi Parmar

Pageof 1

Frequent Collaborators

1 joint publications

Brandon M Huffman

1 joint publications

Hanrong Feng

1 joint publications

Kalindi Parmar

1 joint publications

Junning Wang

1 joint publications

Kevin S Kapner

1 joint publications

Bose Kochupurakkal

1 joint publications

David B Martignetti

1 joint publications

Golbahar Sadatrezaei

1 joint publications

Thomas A Abrams

1 joint publications

Leah H Biller

Frequent Collaborators

1 joint publications

Brandon M Huffman

1 joint publications

Hanrong Feng

1 joint publications

Kalindi Parmar

1 joint publications

Junning Wang

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

See more related videos

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

See more related videos